Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
RFK Jr. to Reinstate 20% of HHS Staff Laid off After DOGE Errors
Argus Research Downgrades Biogen to Hold
Biogen Analyst Ratings
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields
Novartis Secures Third FDA Approval For Its Kidney Disease Portfolio In One Year
BeiGene Discontinues Lung Cancer Drug Study After Interim Data Showed Limited Survival Benefit